SG, Korea signs MRA on medicinal products regulation

The agreement will facilitate trade and access to medicinal products between both countries.

The Health Sciences Authority (HSA) and the Ministry of Food and Drug Safety (MFDS) of Korea signed a mutual recognition agreement (MRA) to establish the requirements of Good Manufacturing Practice (GMP) 1 for medicinal products.

The agreement will enable the mutual recognition of GMP certificates and inspection outcomes of medicine manufacturers from the two countries.

It will reduce duplicative onsite GMP inspections, reducing the regulatory burden on pharmaceutical and biologics manufacturers in both countries.

The MRA will also facilitate trade and access to medicinal products for consumers in both countries

“Signing the MRA will pave the way for timely supply of safer and more effective medicinal products to the public by bilaterally recognising the results of conformity assessment of the two nations based on mutual trust,” Korean Minister Oh Yu-Kyoung said.

Follow the link for more news on

healthcare

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia